Experts (Vall d'Hebron Barcelona Hospital Campus): Difference between revisions
From Beacon
m (Update categories.) |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forpatients</span> <span style="display:none">forproviders</span> | <span style="display:none">forpatients</span> <span style="display:none">forproviders</span> | ||
<span style="display:none">spaincountry</span> | |||
Go back to [[Vall d'Hebron Barcelona Hospital Campus]] page | Go back to [[Vall d'Hebron Barcelona Hospital Campus]] page | ||
| Line 8: | Line 9: | ||
'''[https://vhio.net/es/pf/grupo-de-biologia-computacional-del-cancer/ Cancer Computational Biology]''' | '''[https://vhio.net/es/pf/grupo-de-biologia-computacional-del-cancer/ Cancer Computational Biology]''' | ||
'''[https://vhio.net/es/pf/grupo-de- | '''[https://vhio.net/es/pf/grupo-de-celulas-madre-y-cancer/ Cellular Plasticity and Cancer]''' | ||
'''[https://vhio.net/es/pf/grupo-de-desarrollo-clinico-precoz-de-farmacos/ Early clinical drug development]''' | '''[https://vhio.net/es/pf/grupo-de-desarrollo-clinico-precoz-de-farmacos/ Early clinical drug development]''' | ||
| Line 50: | Line 51: | ||
'''[https://vhio.net/es/pf/grupo-de-inmunoterapia-e-inmunologia-de-tumores/ Tumour Immunotherapy and Immunology]''' | '''[https://vhio.net/es/pf/grupo-de-inmunoterapia-e-inmunologia-de-tumores/ Tumour Immunotherapy and Immunology]''' | ||
'''[https://vhio.net/es/pf/grupo-de- | '''[https://vhio.net/es/pf/grupo-de-tumores-del-tracto-gastrointestinal/ Gastrointestinal Tract Tumors]''' | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
